The Fatty Acid Synthase Inhibitor Platensimycin Improves Insulin Resistance without Inducing Liver Steatosis in Mice and Monkeys-Reference-Cited by-同舟云学术

The Fatty Acid Synthase Inhibitor Platensimycin Improves Insulin Resistance without Inducing Liver Steatosis in Mice and Monkeys

Published:2016-10-03 Issue:10 Volume:11 Page:e0164133
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Singh Sheo B.,Kang Ling,Nawrocki Andrea R.,Zhou Dan,Wu Margaret,Previs Stephen,Miller Corey,Liu Haiying,Hines Catherine D. G.,Madeira Maria,Cao Jin,Herath Kithsiri,Wang Liangsu,Kelley David E.,Li Cai,Guan Hong-Ping^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference31 articles.

1. Human fatty liver disease: old questions and new insights;JC Cohen;Science,2011

2. Fatty acid metabolism: target for metabolic syndrome;SJ Wakil;Journal of lipid research,2009

3. Fatty acid synthesis and its regulation;SJ Wakil;Annu Rev Biochem,1983

4. Human fatty acid synthase: properties and molecular cloning;A Jayakumar;Proc Natl Acad Sci U S A,1995

5. Hepatic regulation of fatty acid synthase by insulin and T3: evidence for T3 genomic and nongenomic actions;A Radenne;Am J Physiol Endocrinol Metab,2008

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Fatty Acid Synthase Reduces Aortic Atherosclerosis and Inflammation;2024-05-08

2. Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity models;JCI Insight;2023-09-08

3. Review on PLGA Polymer Based Nanoparticles with Antimicrobial Properties and Their Application in Various Medical Conditions or Infections;Polymers;2023-08-30

4. Lycopene ameliorates hyperlipidemia via potentiation of AMP-activated protein kinase and inhibition of ATP-citrate lyase in diabetic hyperlipidemic rat model;Life Sciences;2022-11

5. Diterpenoids from Streptomyces : Structures, Biosyntheses and Bioactivities;ChemBioChem;2022-06-20